🇺🇸 FDA
Pipeline program

Tenofovir DF

GS-US-174-0144

Phase 3 small_molecule active

Quick answer

Tenofovir DF for Chronic Hepatitis B is a Phase 3 program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences Ireland UC
Indication
Chronic Hepatitis B
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials